DSM B.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
23 sep 2010 - 10:31
Statutaire naam
DSM B.V.
Titel
DSM announces management changes
Bericht
Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management changes:
Mr. Anton Robek (1959), most recently President and CEO of DSM Melamine, will be appointed as Senior Vice President of DSM's Emerging Business Area (EBA) DSM Bio-based Products & Services with effect from 1 January 2011. In this role he will build on the success of this EBA, formerly named DSM White Biotechnology, and drive its further commercialization as outlined in the strategy: 'DSM in motion: driving focused growth'. Anton Robek will report to Mr. Rob van Leen, DSM's Chief Innovation Officer.
Gerelateerde downloads
Datum laatste update: 27 juli 2024